Assessment of Cone-Beam Breast Computed Tomography for Predicting Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer: A Prospective Study

Figure 3

Sagittal images before and during neoadjuvant chemotherapy of pathologic responder (a) and nonresponder (b) from 56-year-old and 31-year-old women with right side invasive breast cancer, respectively. The enhancement curve was plotted by measuring density changes in each mass during the enhancement scan. NAC: Neoadjuvant chemotherapy.

(a)

(b)